Full Text View
Tabular View
No Study Results Posted
Related Studies
Combinations of Pharmacologic Smoking Cessation Treatments
This study has been completed.
Study NCT00018187   Information provided by Department of Veterans Affairs
First Received: July 3, 2001   Last Updated: January 20, 2009   History of Changes

July 3, 2001
January 20, 2009
November 1998
 
 
 
Complete list of historical versions of study NCT00018187 on ClinicalTrials.gov Archive Site
 
 
 
Combinations of Pharmacologic Smoking Cessation Treatments
Combinations of Pharmacologic Smoking Cessation Treatments

The purpose of this study is to test the effectiveness of a combination of the drugs bupropion and mecamylamine along with a nicotine patch as a therapy for smoking cessation.

 
Phase I
Interventional
Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study
Smoking
  • Drug: Bupropion
  • Drug: Mecamylamine
  • Drug: Nicotine Patch
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
 
June 2001
 

Subjects must be a smoker between 20 and 40 years old, have smoked at least 20 cigarettes per day for at least 2 years, wish to stop smoking and be in good general health

Both
20 Years to 40 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00018187
 
ADRD-011-98S
Department of Veterans Affairs
 
Investigator: Neil Hartman, M.D.
Department of Veterans Affairs
May 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP